How to Verify a Peptide COA: A Procurement Checklist

Why COA Verification Matters in Research Procurement

A Certificate of Analysis (COA) is the document a laboratory supplier issues for each production lot of a research compound. It records what the compound is, how pure it is, who analyzed it, when, and by what method. In research procurement, the COA is the only document that links the physical vial on a bench to the analytical work performed before shipping. A vendor without a verifiable COA is, in practical terms, a vendor without verifiable inventory.

FYH Peptides publishes the Certificate of Analysis for every lot we ship before that lot is offered for sale. This article describes what a complete COA must contain so that any researcher — whether buying from us or from another laboratory supplier — can evaluate the document on its own terms.

Required Fields on a Complete COA

A research-peptide COA that is missing any of the following fields should be treated as incomplete:

• Compound name and synonym. The chemical name on the COA must match the label on the vial. Trade names without a chemical name, or chemical names with no sequence, are red flags.
• Lot or batch number. The lot number on the COA must match the lot number printed or stamped on the vial. A generic catalog COA with no lot number is a marketing document, not an analytical report.
• Analyzing laboratory. The name and identifier of the laboratory that performed the analysis. Independent third-party laboratories are the standard reference. "Tested in-house" without external verification is the most common quality gap reported in the procurement literature.
• Date of analysis. A dated report from within the last twelve months. Older reports may not reflect the current lot in inventory.
• Analytical methods. The methods used to characterize the lot. For peptides, the expected combination is reversed-phase HPLC for purity and mass spectrometry for identity. A COA that lists only HPLC is incomplete (see next section).
• Measured purity (%). A specific numeric value, not a generic claim such as "high purity."
• Mass spectrometry identity confirmation. The observed mass should be reported alongside the calculated mass for the labeled sequence.
• Storage and handling conditions. Lyophilized peptides are typically reported as stable at -20 °C, protected from light and moisture.

The Distinction Between Purity (HPLC) and Identity (Mass Spectrometry)

Purity and identity are two different questions and require two different methods. Reversed-phase HPLC separates the target compound from impurities and degradation products and reports the relative proportion of the target peak — this answers "how much of the sample is the target molecule." Mass spectrometry measures the molecular mass of the target peak and confirms whether that mass matches the molecular mass of the labeled sequence — this answers "is the target molecule actually what the label says it is."

A COA that reports HPLC purity but does not confirm identity by mass spectrometry tells the researcher the sample is consistent, but not what the sample is. In the published procurement literature, this is described as an incomplete report. Complete COAs include both methods.

Lot Traceability: The Vial Must Match the Report

The decisive verification step happens after the package arrives. Compare the lot number physically present on the vial label to the lot number printed on the Certificate of Analysis that was published for that compound. The two must match exactly. If the vendor publishes a generic COA that is not lot-specific, the link between the bench material and the analytical report is broken regardless of what the report itself claims.

FYH Peptides assigns every production lot a unique identifier, prints that identifier on the vial label, and publishes the matching COA on the public product page and on the COA index. Any researcher receiving a FYH vial can confirm in under a minute that the document they read before purchasing describes the material they now hold.

Third-Party Laboratory vs In-House Testing

In-house testing is reported by the same organization that produces and sells the compound. Third-party testing is reported by an independent laboratory with no commercial interest in the result. In research procurement, third-party reports are the standard of evidence because they remove the conflict of interest inherent in self-reported quality data.

When evaluating a COA, look for the laboratory's name, address, and an independent point of contact. If the report does not name an analyzing laboratory at all — or names a laboratory that is the same legal entity as the vendor — treat the analysis as in-house and weigh it accordingly.

Common Patterns That Indicate an Unverifiable COA

The procurement literature on research chemicals documents a recurring set of patterns that distinguish unverifiable reports from legitimate ones. The following list summarizes the patterns most frequently described:

• "COA available upon request" with no document published before sale. Legitimate vendors publish the report so the researcher can inspect it as part of the purchase decision.
• A single catalog-wide COA used for every lot. This indicates no lot-level traceability.
• HPLC purity reported without mass spectrometry identity. Incomplete by reference-method standards.
• Image-only COA (a flat JPG or PNG) with no underlying source document. These are the most commonly altered reports.
• Analysis date older than twelve months on a lot currently in inventory.
• No analyzing laboratory named, or a laboratory name that returns no independent search results.
• Numeric values that round suspiciously (every lot reporting exactly 99.0%, for example, rather than the natural distribution analytical work produces).

A Five-Minute Verification Procedure

The following procedure works for any research-peptide vendor and takes a few minutes per order:

1. Open the product page for the specific compound and locate the linked Certificate of Analysis. If no COA is published, stop here.
2. Confirm the COA names an analyzing laboratory, includes the analysis date, lists a specific lot number, and reports both HPLC purity and mass spectrometry identity.
3. Save or screenshot the COA before placing the order — this is the document the delivered material is expected to match.
4. When the vial arrives, compare the lot number printed on the vial label to the lot number on the saved COA. They must match.
5. Confirm the compound name on the vial matches the compound name on the COA, and that the reported purity figure is consistent with what was published before the order.

If any step diverges, the vendor's documented refund or replacement procedure should apply. FYH Peptides replaces or refunds any lot whose vial does not match its published COA, without dispute, upon presentation of the lot number.

Summary

A complete research-peptide Certificate of Analysis identifies the compound, names the analyzing third-party laboratory, dates the analysis, ties the report to a specific lot number that matches the vial label, and reports both HPLC purity and mass spectrometry identity. Researchers procuring laboratory peptides should treat any report missing one of these elements as incomplete, and should compare the lot number on each received vial to the published COA before bringing the material into use.